Seres Therapeutics IPO Soars, Raises $133 Million
Seres Therapeutics (MCRB) turned in the strongest performance of several initial public offerings that began trading Friday. Seres priced at 18, above the high end of its 15 to 17 expected range. Seres stock was up 80%, near 33, in early afternoon trading on the stock market today. The company offered 7.4 million shares, raising $133 million. The company is developing a class of biological drugs to treat metabolic, inflammatory and infectious